Literature DB >> 20198527

Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.

Jennifer E Iudicello1, Steven P Woods, Ofilio Vigil, J Cobb Scott, Mariana Cherner, Robert K Heaton, J Hampton Atkinson, Igor Grant.   

Abstract

Chronic use of methamphetamine (MA) is associated with neuropsychological dysfunction and affective distress. Some normalization of function has been reported after abstinence, but little in the way of data is available on the possible added benefits of long-term sobriety. To address this, we performed detailed neuropsychological and affective evaluations in 83 MA-dependent individuals at a baseline visit and following an average one-year interval period. Among the 83 MA-dependent participants, 25 remained abstinent, and 58 used MA at least once during the interval period. A total of 38 non-MA-addicted, demographically matched healthy comparison (i.e., HC) participants were also examined. At baseline, both MA-dependent participants who were able to maintain abstinence and those who were not performed significantly worse than the healthy comparison subjects on global neuropsychological functioning and were significantly more distressed. At the one-year follow-up, both the long-term abstainers and healthy comparison groups showed comparable global neuropsychological performance and affective distress levels, whereas the MA-dependent group who continued to use MA were worse than the comparison participants in terms of global neuropsychological functioning and affective distress. An interaction was observed between neuropsychological impairment at baseline, MA abstinence, and cognitive improvement, with abstinent MA-dependent participants who were neuropsychologically impaired at baseline demonstrating significantly and disproportionately greater improvement in processing speed and slightly greater improvement in motor abilities than the other participants. These results suggest partial recovery of neuropsychological functioning and improvement in affective distress upon sustained abstinence from MA that may extend beyond a year or more.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198527      PMCID: PMC2911490          DOI: 10.1080/13803390903512637

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  40 in total

1.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study.

Authors:  T Ernst; L Chang; M Leonido-Yee; O Speck
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

3.  Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.

Authors:  Linda Chang; Thomas Ernst; Oliver Speck; Hetal Patel; Menaka DeSilva; Maria Leonido-Yee; Eric N Miller
Journal:  Psychiatry Res       Date:  2002-06-15       Impact factor: 3.222

4.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; M Leonido-Yee; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; J Logan; C Wong; E N Miller
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

5.  Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.

Authors:  Thomas E Nordahl; Ruth Salo; Kate Possin; David R Gibson; Neil Flynn; Martin Leamon; Gantt P Galloway; Adolf Pfefferbaum; Daniel M Spielman; Elfar Adalsteinsson; Edith V Sullivan
Journal:  Psychiatry Res       Date:  2002-11-30       Impact factor: 3.222

6.  Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Authors:  Y Sekine; M Iyo; Y Ouchi; T Matsunaga; H Tsukada; H Okada; E Yoshikawa; M Futatsubashi; N Takei; N Mori
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

7.  A meta-analysis of the neuropsychological sequelae of HIV infection.

Authors:  Mark Reger; Robert Welsh; Jill Razani; David J Martin; Kyle B Boone
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

8.  Status of methamphetamine users 2-5 years after outpatient treatment.

Authors:  Richard A Rawson; Alice Huber; Paul Brethen; Jeanne Obert; Vikas Gulati; Steven Shoptaw; Walter Ling
Journal:  J Addict Dis       Date:  2002

9.  Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.

Authors:  Ari D Kalechstein; Thomas F Newton; Michael Green
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

10.  Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.

Authors:  Mariana Cherner; Paola Suarez; Corinna Casey; Robert Deiss; Scott Letendre; Thomas Marcotte; Florin Vaida; J Hampton Atkinson; Igor Grant; Robert K Heaton
Journal:  Drug Alcohol Depend       Date:  2009-10-07       Impact factor: 4.492

View more
  39 in total

1.  The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.

Authors:  David E Vance; Pariya L Fazeli; Joan S Grant; Larry Z Slater; James L Raper
Journal:  J Neurosci Nurs       Date:  2013-10       Impact factor: 1.230

2.  Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.

Authors:  Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant
Journal:  Aust N Z J Psychiatry       Date:  2012-02       Impact factor: 5.744

3.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

4.  Assessing and treating forgetfulness and cognitive problems in adults with HIV.

Authors:  David E Vance; Pariya L Fazeli; Linda Moneyham; Norman L Keltner; James L Raper
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jan-Feb       Impact factor: 1.354

5.  Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis.

Authors:  Jessica L Montoya; Anya Umlauf; Ian Abramson; Jayraan Badiee; Steven Paul Woods; J Hampton Atkinson; Igor Grant; David J Moore
Journal:  J Affect Disord       Date:  2013-08-16       Impact factor: 4.839

Review 6.  Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

7.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

8.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

9.  Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine.

Authors:  Diane M Herbeck; Mary-Lynn Brecht
Journal:  J Addict Dis       Date:  2013

10.  Time-based prospective memory predicts engagement in risk behaviors among substance users: results from clinical and nonclinical samples.

Authors:  Michael Weinborn; Jonson Moyle; Romola S Bucks; Werner Stritzke; Angela Leighton; Steven Paul Woods
Journal:  J Int Neuropsychol Soc       Date:  2013-01-14       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.